Predicting cutaneous malignant melanoma patients' survival using deep learning: a retrospective cohort study.

Journal: Journal of cancer research and clinical oncology
Published Date:

Abstract

BACKGROUND: Cutaneous malignant melanoma (CMM) has the worst prognosis among skin cancers, especially metastatic CMM. Predicting its prognosis accurately could direct clinical decisions.

Authors

  • Siyu Cai
    Dermatology Department, General Hospital of Western Theater Command PLA, No. 270, Rongdu Avenue, Chengdu, 610083, Sichuan, China.
  • Wei Li
    Department of Nephrology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
  • Cong Deng
    Division of TCM, Guangzhou Nansha Central Hospital, Guangzhou First People's Hospital, Guangzhou, 510180, China.
  • Qiao Tang
    Dermatology Department, Medical Center Hospital of Qionglai City, No. 172 Xinglin Road, Qionglai City, Chengdu, 611500, Sichuan, China.
  • Zhou Zhou